HERMIONE: A randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer
- Miller, K.
- Cortes, J.
- Hurvitz, S.A.
- Krop, I.E.
- Tripathy, D.
- Verma, S.
- Riahi, K.
- Reynolds, J.G.
- Wickham, T.J.
- Molnar, I.
- Yardley, D.A.
Revista:
BMC Cancer
ISSN: 1471-2407
Año de publicación: 2016
Volumen: 16
Número: 1
Tipo: Artículo